Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

NCT06931145 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: Benmelstobart
DRUG: Anlotinib
DRUG: Carboplatin or cisplatin
DRUG: Etoposide

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]